MedTrace Logo

Automated Robotic TCD in Traumatic Brain Injury

NCT05848297 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-10-22

No results posted yet for this study

Summary

This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience

Conditions

  • Brain Injuries, Traumatic

Interventions

DEVICE

Transcranial Doppler ultrasonography (TCD)

Portable, bedside, non-invasive diagnostic tool used for real-time assessment of cerebral hemodynamics

Sponsors & Collaborators

  • Wake Forest University

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Shraddha Mainali · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2026-05-31
Completion
2026-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05848297 on ClinicalTrials.gov